{"id":"W2502507727","doi":"10.1200/jco.2015.33.15_suppl.4503","title":"First-line randomized phase II study of gemcitabine/cisplatin plus apatorsen or placebo in patients with advanced bladder cancer: The International Borealis-1 trial.","year":2015,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Hôpital Notre-Dame; BC Cancer Agency","funders":"","keywords":"Medicine; Gemcitabine; Internal medicine; Bladder cancer; Chemotherapy; Placebo; Clinical endpoint; Gastroenterology; Cancer; Oncology; Cisplatin; Surgery; Randomized controlled trial; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002053115,0.002409441,0.003871798,0.0004950003,0.0004659061,0.001422113,0.001332524,0.002158255,0.01026239],"category_scores_gemma":[0.001554942,0.0008806834,0.002091944,0.0004863101,0.001315795,0.001478919,0.000624913,0.00385347,0.001862791],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001098416,"about_ca_system_score_gemma":0.001386294,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001025393,"about_ca_topic_score_gemma":0.002715253,"domain_scores_codex":[0.9993641,0.0003763084,0.00002399569,0.0001061508,0.00003358238,0.00009593096],"domain_scores_gemma":[0.9991818,0.0001378715,0.0001971652,0.00007234669,0.000041702,0.0003691383],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9788072,0.005879879,0.0006986928,0.0003717213,0.0006130854,0.00002838054,0.00003942071,0.0003590525,0.001501071,0.000103328,0.0009865855,0.01061154],"study_design_scores_gemma":[0.9294838,0.06741108,0.001350312,0.00002255145,0.0003348789,0.00002876601,0.00001851766,0.0003275982,0.0001971099,0.00016344,0.0006487508,0.00001321247],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.976345,0.006277872,0.000834041,0.001645837,0.0008811178,0.007032049,0.002874884,0.0002248568,0.003884255],"genre_scores_gemma":[0.97324,0.003404776,0.001829141,0.002838854,0.0006702404,0.008080145,0.003384912,0.00006112863,0.006490917],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01026239,"threshold_uncertainty_score":0.03433114,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1214847151290184,"score_gpt":0.4716318890845635,"score_spread":0.3501471739555451,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}